Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

NCT04046159 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

810

Enrollment

OTHER

Sponsor class

Conditions

Breast Ductal Carcinoma in Situ

Interventions

DRUG: Low-dose tamoxifen
RADIATION: Whole breast radiotherapy

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]